sur Bellevue Asset Management AG
Bellevue Asset Management Enhances Healthcare Research Team
Bellevue Asset Management AG has announced the expansion of its healthcare research team with the addition of two seasoned analysts. Guy Bettschart, CFA, joins as a Senior Healthcare Equity Research Analyst, while Dr. Markus Schweiger becomes a Healthcare Equity Research Analyst. This strategic move aims to bolster Bellevue’s capabilities in the pharmaceutical and biotechnology sectors.
Bettschart has over six years of experience in the financial industry, including significant roles at Kieger AG and Julius Baer. Dr. Schweiger adds extensive expertise in medical and biological sciences, having worked as a biotech analyst in New York.
Terence McManus, Bellevue's Head of Global Healthcare, stated that the new hires enhance their biopharma research capabilities. The healthcare sector has recently seen improved investor sentiment and stock performance, partly due to clearer US government policies on drug pricing.
R. P.
Copyright © 2025 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de Bellevue Asset Management AG